High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.
Data(s) |
2004
|
---|---|
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
O'Sullivan , J , Norman , A R , McCready , V R , Flux , G , Cook , G , Johnson , B , Treleaven , J & Dearnaley , D P 2004 , ' High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone. ' Journal of Clinical Oncology , vol 22 , pp. 397S-397S . |
Tipo |
article |